Study of macupatide for weight loss in Japanese adults with overweight or obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational drug called macupatide to see if it can help people with overweight or obesity lose weight. It is for Japanese adults who do not have type 2 diabetes and have had a stable weight for the past 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Japanese adult (assigned male or female at birth) and agree to use contraception if needed.
- Your body mass index (BMI) is 25 or higher.
- Your weight has been stable (less than 5% change) for the past 3 months.
- You do not have type 1 or type 2 diabetes.
- You have no history of significant allergies, severe psychiatric disorders, chronic heart, liver, or kidney conditions, or certain gastrointestinal issues.
- You have not used prescription weight-loss medications in the past 3 months and have not had obesity surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two new medicines, alone or together, to see if they help with weight loss and blood sugar control in adults who have type 2 diabetes and are overweight or have obesity.
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This trial tests a new medication, Ribupatide, to see if it helps people with obesity or overweight who also have weight-related health problems. You cannot have diabetes to join.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.